Should You Buy Harmonicare Medical Holdings Limited (HKG:1509) Now?

Harmonicare Medical Holdings Limited (HKG:1509), a healthcare company based in China, saw a double-digit share price rise of over 10% in the past couple of months on the SEHK. As a small cap stock, hardly covered by any analysts, there is generally more of an opportunity for mispricing as there is less activity to push the stock closer to fair value. Is there still an opportunity here to buy? Let’s take a look at Harmonicare Medical Holdings’s outlook and value based on the most recent financial data to see if the opportunity still exists.

See our latest analysis for Harmonicare Medical Holdings

What’s the opportunity in Harmonicare Medical Holdings?

Harmonicare Medical Holdings appears to be overvalued according to my relative valuation model. In this instance, I’ve used the price-to-equity (PE) ratio given that there is not enough information to reliably forecast the stock’s cash flows. I find that Harmonicare Medical Holdings’s ratio of 53.36x is above its peer average of 29.97x, which suggests the stock is overvalued compared to the Healthcare industry. But, is there another opportunity to buy low in the future? Since Harmonicare Medical Holdings’s share price is quite volatile, this could mean it can sink lower (or rise even further) in the future, giving us another chance to invest. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.

What does the future of Harmonicare Medical Holdings look like?

SEHK:1509 Future Profit August 14th 18
SEHK:1509 Future Profit August 14th 18
Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company’s future expectations. In Harmonicare Medical Holdings’s case, its revenues over the next few years are expected to grow by 75.51%, indicating a highly optimistic future ahead. If expense does not increase by the same rate, or higher, this top line growth should lead to stronger cash flows, feeding into a higher share value.

What this means for you:

Are you a shareholder? It seems like the market has well and truly priced in 1509’s positive outlook, with shares trading above its fair value. However, this brings up another question – is now the right time to sell? If you believe 1509 should trade below its current price, selling high and buying it back up again when its price falls towards its real value can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.

Are you a potential investor? If you’ve been keeping an eye on 1509 for a while, now may not be the best time to enter into the stock. The price has surpassed its industry peers, which means it is likely that there is no more upside from mispricing. However, the positive outlook is encouraging for 1509, which means it’s worth diving deeper into other factors in order to take advantage of the next price drop.

Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on Harmonicare Medical Holdings. You can find everything you need to know about Harmonicare Medical Holdings in the latest infographic research report. If you are no longer interested in Harmonicare Medical Holdings, you can use our free platform to see my list of over 50 other stocks with a high growth potential.

To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.